It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...

Follow the latest COVID-19 Vaccine news stories and headlines. Get breaking news alerts when you download the ABC News App and subscribe to COVID-19 Vaccine notifications.

Biotech firm Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to ...

Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a ...

Regulatory authorities in the US are investigating a possible link between the new Pfizer/BioNTech bivalent COVID-19 booster ... or another bivalent shot from rival Moderna – also approved ...

Moderna says it has become the first company in the pharma sector with phase 3 data on a combined vaccine for both COVID-19 and influenza and will soon be ready to discuss “next steps” with ...

COVID-19 has impacted nearly every aspect of life. Although tens of thousands of cases continue to occur each week, the world ...

Moderna stock has been under pressure ... U.S. Food and Drug Administration (FDA) for its landmark COVID-19 vaccine in late 2020. The shot played an instrumental role in tackling the global ...

As Moderna (NASDAQ: MRNA ... biggest earning potential that could be approved are its combination shot for influenza and COVID, its influenza vaccine, and its next-generation COVID vaccine.

The amended lawsuit, filed in July 2022, sought a court order requesting that the agency reconsider granting authorization for Pfizer and Moderna Covid vaccines for children. Image An 11-year-old ...

Moderna has big plans for the next few ... earning potential that could be approved are its combination shot for influenza and COVID, its influenza vaccine, and its next-generation COVID vaccine.

Here, we explain the facts behind several more of Robert F. Kennedy Jr.’s claims during his two Senate hearings as nominee ...